XWELL Gross Margin 2010-2025 | XWEL
Current and historical gross margin for XWELL (XWEL) over the last 10 years. The current gross profit margin for XWELL as of March 31, 2025 is %.
| XWELL Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.03B | $0.01B | 22.58% |
| 2024-12-31 | $0.03B | $0.01B | 27.27% |
| 2024-09-30 | $0.03B | $0.01B | 27.27% |
| 2024-06-30 | $0.03B | $0.01B | 25.00% |
| 2024-03-31 | $0.03B | $0.01B | 19.35% |
| 2023-12-31 | $0.03B | $0.00B | 13.79% |
| 2023-09-30 | $0.03B | $0.00B | 10.00% |
| 2023-06-30 | $0.03B | $0.00B | 8.82% |
| 2023-03-31 | $0.04B | $0.00B | 7.50% |
| 2022-12-31 | $0.06B | $0.01B | 19.30% |
| 2022-09-30 | $0.08B | $0.02B | 30.77% |
| 2022-06-30 | $0.09B | $0.04B | 38.30% |
| 2022-03-31 | $0.09B | $0.04B | 40.45% |
| 2021-12-31 | $0.07B | $0.03B | 41.89% |
| 2021-09-30 | $0.05B | $0.02B | 35.56% |
| 2021-06-30 | $0.02B | $0.00B | 11.11% |
| 2021-03-31 | $0.01B | 0 | 0.00% |
| 2020-12-31 | $0.01B | $0.00B | -37.50% |
| 2020-09-30 | $0.02B | $0.00B | 5.26% |
| 2020-06-30 | $0.03B | $0.01B | 15.63% |
| 2020-03-31 | $0.05B | $0.01B | 20.00% |
| 2019-12-31 | $0.05B | $0.01B | 22.45% |
| 2019-09-30 | $0.05B | $0.01B | 22.00% |
| 2019-06-30 | $0.05B | $0.01B | 22.00% |
| 2019-03-31 | $0.05B | $0.01B | 22.00% |
| 2018-12-31 | $0.05B | $0.01B | 21.57% |
| 2018-09-30 | $0.05B | $0.01B | 23.53% |
| 2018-06-30 | $0.05B | $0.01B | 21.57% |
| 2018-03-31 | $0.05B | $0.01B | 19.61% |
| 2017-12-31 | $0.05B | $0.01B | 18.37% |
| 2017-09-30 | $0.03B | $0.01B | 18.75% |
| 2017-06-30 | $0.02B | $0.00B | 18.18% |
| 2017-03-31 | $0.02B | $0.01B | 35.00% |
| 2016-12-31 | $0.01B | $0.01B | 45.45% |
| 2016-09-30 | $0.04B | $0.03B | 71.79% |
| 2015-12-31 | $0.02B | $0.02B | 100.00% |
| 2015-03-31 | $0.00B | $0.00B | 100.00% |
| 2014-12-31 | $0.00B | $0.00B | 100.00% |
| 2014-03-31 | $0.00B | $0.00B | 100.00% |
| 2013-06-30 | $0.00B | $0.00B | -200.00% |
| 2011-06-30 | $0.00B | 0 | 0.00% |
| 2011-03-31 | $0.00B | 0 | 0.00% |
| 2010-12-31 | $0.00B | 0 | 0.00% |
| 2010-06-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.181B | 25.92 |
| Elevance Health (ELV) | United States | $85.871B | 11.08 |
| CVS Health (CVS) | United States | $80.417B | 10.00 |
| Cencora (COR) | United States | $56.019B | 19.49 |
| Natera (NTRA) | United States | $22.833B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 33.64 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $13.000B | 13.76 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.955B | 0.00 |
| CochLear (CHEOY) | Australia | $11.511B | 0.00 |
| ICON (ICLR) | Ireland | $11.274B | 10.48 |
| Revvity (RVTY) | United States | $10.891B | 18.74 |
| Doximity (DOCS) | United States | $10.250B | 47.45 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| HealthEquity (HQY) | United States | $9.777B | 42.83 |
| Avantor (AVTR) | United States | $9.070B | 13.18 |
| Medpace Holdings (MEDP) | United States | $8.989B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.365B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.034B | 13.78 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 38.03 |
| Bausch + Lomb (BLCO) | Canada | $4.068B | 23.98 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Alignment Healthcare (ALHC) | United States | $3.031B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.955B | 38.43 |
| Concentras Parent (CON) | United States | $2.766B | 15.98 |
| Organon (OGN) | United States | $2.477B | 2.63 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.55 |
| Premier (PINC) | United States | $1.908B | 14.48 |
| Progyny (PGNY) | United States | $1.826B | 40.19 |
| PACS (PACS) | United States | $1.550B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Teladoc Health (TDOC) | United States | $1.249B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.194B | 9.09 |
| Establishment Labs Holdings (ESTA) | $1.075B | 0.00 | |
| CareDx (CDNA) | United States | $1.075B | 16.78 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.768B | 7.19 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.753B | 11.41 |
| Embecta (EMBC) | United States | $0.608B | 4.09 |
| LifeMD (LFMD) | United States | $0.559B | 0.00 |
| Enhabit (EHAB) | United States | $0.538B | 44.25 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| SBC Medicals (SBC) | United States | $0.502B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.95 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.00 |
| KindlyMD (NAKA) | United States | $0.103B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |